Pharmacy is set to play a major role in potentially reducing community
stroke risk, with the introduction of new technology to specifically assess
the two greatest risk factors for stroke: elevated blood pressure and atrial
fibrillation. The range of Microlife blood pressure monitors with AFIB
technology has been welcomed by medical experts who describe pharmacy
screening as an “important way to identify many of the 100,000 Australians
with undiagnosed atrial fibrillation”. Ask about the pharmacy-only deal.
Stockist: 1800 252 467
RRP: $190.00
Website: www.covidien.com.auThe above article was sent to subscribers in Pharmacy Daily's issue from 07 May 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 14
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.